amitriptyline sold brand name elavil among others tricyclic antidepressant primarily used treat major depressive disorder variety pain syndromes neuropathic pain fibromyalgia migraine tension due frequency prominence side effects amitriptyline generally considered secondline therapy common side effects dry mouth drowsiness dizziness constipation weight gain note sexual dysfunction observed primarily males glaucoma liver toxicity abnormal heart rhythms rare serious side effects blood levels amitriptyline vary significantly one person amitriptyline interacts many medications potentially aggravating side effects amitriptyline discovered late scientists merck approved us food drug administration fda world health organizations list essential available generic commonly prescribed medication united states million amitriptyline indicated treatment major depressive disorder neuropathic pain prevention migraine chronic tension headache used treatment nocturnal enuresis children older treatments amitriptyline effective rarely used firstline antidepressant due higher toxicity overdose generally poorer tried depression secondline therapy failure treatmentresistant adolescent cancerrelated amitriptyline better placebo however number treated patients studies small sometimes used treatment depression parkinsons supporting evidence amitriptyline alleviates painful diabetic neuropathy recommended variety guidelines first second line effective indication gabapentin pregabalin less well amitriptyline effective relieving pain duloxetine combination treatment amitriptyline pregabalin offers additional pain relief people whose pain adequately controlled one medication amitriptyline certain formulations may also induce level sciaticnerve blockade needed local anaesthesia demonstrated superior potency bupivacaine customary longacting local anaesthetic low doses amitriptyline moderately improve sleep disturbances reduce pain fatigue associated recommended fibromyalgia accompanied depression association scientific medical societies secondline option fibromyalgia exercise first line option european league combinations amitriptyline fluoxetine melatonin may reduce fibromyalgia pain better either medication lowquality evidence amitriptyline may reduce pain cancer patients recommended second line therapy nonchemotherapyinduced neuropathic mixed neuropathic pain opioids provide desired moderate evidence exists favor amitriptyline use atypical facial amitriptyline ineffective hivassociated multiple sclerosis frequently used treat painful paresthesias arms legs eg burning sensations pins needles stabbing pains caused damage pain regulating pathways brain spinal amitriptyline probably effective prevention periodic migraine adults amitriptyline similar efficacy venlafaxine topiramate carries higher burden adverse effects many patients even small doses amitriptyline helpful may allow minimization side amitriptyline significantly different placebo used prevention migraine amitriptyline may reduce frequency duration chronic tension headache associated worse adverse effects mirtazapine overall amitriptyline recommended tension headache prophylaxis along lifestyle advice include avoidance analgesia amitriptyline effective treatment irritable bowel syndrome however side effects reserved select patients agents insufficient evidence support use abdominal pain children functional gastrointestinal tricyclic antidepressants decrease frequency severity duration cyclic vomiting syndrome episodes amitriptyline commonly used recommended firstline agent amitriptyline may improve pain urgency intensity associated bladder pain syndrome used management amitriptyline used treatment nocturnal enuresis children however effect sustained treatment ends alarm therapy gives better short longterm us amitriptyline commonly used children adhd adjunct stimulant medications without evidence guideline supporting many physicians uk us also commonly prescribe amitriptyline however cochrane reviewers able find randomized controlled studies would support refute similarly major systematic review network metaanalysis medications treatment insomnia published found little evidence inform use amitriptyline known contraindications amitriptyline amitriptyline used caution patients epilepsy impaired liver function pheochromocytoma urinary retention prostate enlargement hyperthyroidism pyloric patients rare condition shallow anterior chamber eyeball narrow anterior chamber angle amitriptyline may provoke attacks acute glaucoma due dilation pupil may aggravate psychosis used depression schizophrenia precipitate switch mania bipolar poor metabolizers avoid amitriptyline due increased side effects necessary use half dose amitriptyline used pregnancy lactation ssris shown frequent side effects occurring users dry mouth drowsiness dizziness constipation weight gain average common side effects headache problems amblyopia blurred vision tachycardia increased appetite tremor fatigueastheniafeeling slowed literature review abnormal movements amitriptyline found drug associated various movement disorders particularly dyskinesia dystonia myoclonus stuttering restless legs syndrome less common less common side effect amitriptyline urination problems amitriptylineassociated sexual dysfunction occurring frequency seems mostly confined males depression expressed predominantly erectile dysfunction low libido disorder lesser frequency ejaculatory orgasmic problems rate sexual dysfunction males treated indications depression females significantly different liver tests abnormalities occur patients amitriptyline usually mild asymptomatic consistently elevated alanine transaminase increases enzymes threshold liver toxicity uncommon cases clinically apparent liver toxicity nevertheless amitriptyline placed group antidepressants greater risks hepatic amitriptyline prolongs qt prolongation relatively small therapeutic becomes severe symptoms treatment overdose largely tcas including presentation serotonin syndrome adverse cardiac effects british national formulary notes amitriptyline particularly dangerous thus tcas longer recommended firstline therapy depression treatment overdose mostly supportive specific antidote amitriptyline overdose available activated charcoal may reduce absorption given within hours ingestion affected person unconscious impaired gag reflex nasogastric tube may used deliver activated charcoal stomach ecg monitoring cardiac conduction abnormalities essential one found close monitoring cardiac function advised body temperature regulated measures heating blankets necessary cardiac monitoring advised least five days overdose benzodiazepines recommended control seizures dialysis use due high degree protein binding since amitriptyline active metabolite nortriptyline primarily metabolized cytochromes see amitriptylinepharmacology inhibitors enzymes expected exhibit pharmacokinetic interactions amitriptyline according prescribing information interaction inhibitors may increase plasma level however results literature coadministration amitriptyline potent inhibitor paroxetine increase plasma levels amitriptyline twofold main active metabolite nortriptyline combination less potent inhibitors thioridazine levomepromazine affect levels amitriptyline increases nortriptyline moderate inhibitor fluoxetine seem significant effect levels amitriptyline case clinically significant interaction potent inhibitor terbinafine potent inhibitor cytochromes fluvoxamine increases level amitriptyline twofold slightly decreasing level similar changes occur moderate inhibitor cytochromes cimetidine amitriptyline level increases nortriptyline decreases inhibitor ketoconazole elevates amitriptyline level hand cytochrome inducers carbamazepine st johns wort decrease levels amitriptyline oral contraceptives may increase blood level amitriptyline high valproate moderately increases levels amitriptyline nortriptyline unclear prescribing information warns combination amitriptyline monoamine oxidase inhibitors may cause potentially lethal serotonin however prescribing information cautions patients may experience large increase amitriptyline concentration presence however literature states little interaction pharmacokinetic study topiramate increased level amitriptyline nortriptyline amitriptiline counteracts antihypertensive action given amitriptyline anticholinergic agents may result hyperpyrexia paralytic coadministration amitriptyline disulfiram recommended due potential development toxic amitriptyline causes unusual type interaction anticoagulant phenprocoumon great fluctuations prothrombin time amitriptyline inhibits serotonin transporter sert norepinephrine transporter net metabolized nortriptyline stronger norepinephrine reuptake inhibitor augmenting amitriptylines effects norepinephrine reuptake see table section amitriptyline additionally acts potent inhibitor serotonin histamine muscarinic acetylcholine receptors see table section amitriptyline nonselective blocker multiple ion channels particular voltagegated sodium channels voltagegated potassium channels inhibition serotonin norepinephrine transporters amitriptyline results interference neuronal reuptake serotonin norepinephrine since reuptake process important physiologically terminating transmitting activity action may potentiate prolong activity serotonergic adrenergic neurons believed underlie antidepressant activity inhibition norepinephrine reuptake leading increased concentration norepinephrine posterior grey column spinal cord appears mostly responsible analgesic action amitriptyline increased level norepinephrine increases basal activity adrenergic receptors mediate analgesic effect increasing gammaaminobutyric acid transmission among spinal interneurons blocking effect amitriptyline sodium channels may also contribute efficacy pain amitriptyline readily absorbed gastrointestinal tract absorption gradual peak concentration blood plasma reached extensive metabolism first pass liver leads average bioavailability amitriptyline metabolized mostly nortriptyline leading variety hydroxylated metabolites principal one among see metabolism lesser degree nortriptyline main active metabolite amitriptyline antidepressant right nortriptyline reaches higher level blood plasma parent drug amitriptyline greater area curve action important part overall action another active metabolite norepinephrine uptake inhibitor four times weaker nortriptyline blood level comparable nortriptyline cerebrospinal fluid level close proxy brain concentration drug twice higher nortriptylines based suggested significantly contribute antidepressant effects blood levels amitriptyline nortriptyline pharmacokinetics amitriptyline general clearance difference vary widely variability area curve steady state also high makes slow upward titration dose blood amitriptyline bound plasma proteins nortriptyline bound amitriptyline elimination half life nortriptyline within hours amitriptyline eliminated urine mostly unchanged drug excreted elimination feces apparently studied therapeutic levels amitriptyline range ngml ngml amitriptyline metabolite since amitriptyline primarily metabolized genetic variations within genes coding enzymes affect metabolism leading changes concentrations drug increased concentrations amitriptyline may increase risk side effects including anticholinergic nervous system adverse effects decreased concentrations may reduce drugs individuals categorized different types metabolizers depending genetic variations carry metabolizer types include poor intermediate extensive ultrarapid metabolizers individuals extensive normal metabolism amitriptyline poor intermediate metabolizers reduced metabolism drug compared extensive metabolizers patients metabolizer types may increased probability experiencing side effects ultrarapid metabolizers use amitriptyline much faster extensive metabolizers patients metabolizer type may greater chance experiencing pharmacological clinical pharmacogenetics implementation consortium recommends avoiding amitriptyline patients ultrarapid poor metabolizers due risk lack efficacy side effects respectively consortium also recommends considering alternative drug metabolized patients ultrarapid metabolizers reduction starting dose recommended patients intermediate metabolizers poor metabolizers use amitriptyline warranted therapeutic drug monitoring recommended guide dose dutch pharmacogenetics working group also recommends selecting alternative drug monitoring plasma concentrations amitriptyline patients poor ultrarapid metabolizers selecting alternative drug reducing initial dose patients intermediate amitriptyline highly lipophilic molecule octanolwater partition coefficient ph log p free base reported solubility free base amitriptyline water amitriptyline prepared reacting dibenzosuberane chloride heating resulting intermediate product hydrochloric acid eliminate amitriptyline first developed american pharmaceutical company merck late merck approached number clinical investigators proposing conduct clinical trials amitriptyline schizophrenia one researchers frank ayd instead suggested using amitriptyline depression ayd treated patients reported amitriptyline antidepressant properties similar another known time tricyclic antidepressant following us food drug administration approved amitriptyline depression europe due quirk patent law time allowing patents chemical synthesis drug roche lundbeck able independently develop market amitriptyline early according research historian psychopharmacology david healy amitriptyline became much bigger selling drug precursor imipramine two factors first amitriptyline much stronger anxiolytic effect second merck conducted marketing campaign raising clinicians awareness depression clinical english folk singer nick drake died overdose tryptizol senteni masango wife swaziland king mswati died april overdosing amytriptyline film many saints newark amitriptyline referred brand name elavil part plot line amitriptyline english french generic name drug inntooltip international nonproprietary name bantooltip british approved name dcftooltip dénomination commune française amitriptyline hydrochloride usantooltip united states adopted name usptooltip united states pharmacopeia banmtooltip british approved name jantooltip japanese accepted generic name spanish italian dcittooltip denominazione comune italiana amitriptilina german amitriptylin latin embonate salt known amitriptyline embonate banm amitriptyline pamoate along imipramine amitriptyline commonly prescribed first antidepressant children aged years england also prescribed antidepressant along fluoxetine randomized controlled trials investigating amitriptyline efficacy eating disorder httpsenwikipediaorgwikiamitriptyline